Bio Path Holdings Inc reports results for the quarter ended in September - Earnings Summary

Bio Path Holdings

15/11/2022 14:30

* Bio Path Holdings Inc  BPTH.OQ  reported a quarterly
adjusted
loss of 49 cents​​ per share for the quarter ended in September.
The mean expectation of two analysts for the quarter was for a
loss of 45 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Bio Path Holdings Inc's reported EPS for the quarter was a
loss
of 49 cents​.
    * The mean earnings estimate of analysts had risen by
about 4.2%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Bio Path Holdings Inc shares had fallen by 50.2% this
quarter and lost 57.8% so far this year.
    * The company reported a quarterly loss of $3.54 million.
    * Wall Street's median 12-month price target for Bio Path
Holdings
Inc is $11.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
15 at 02:30 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.45          -0.49          Missed
 Jun. 30 2022      -0.49          -0.42          Beat
 Mar. 31 2022      -0.45          -0.47          Missed
 Dec. 31 2021      -0.32          -0.59          Missed